Report Company Directory

Bio-Works Technologies AB

• Bio-Works Technologies AB: 1 director by SmartInsider

BioAdaptives Inc

• BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing by GlobeNewsWire
• BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety by GlobeNewsWire
• BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience by GlobeNewsWire
• BioAdaptives Announces National Launch of Pawpa™ Regen by GlobeNewsWire
• BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements by GlobeNewsWire
• Zeranovia(TM) Weight Loss Product Shows Promising Results in Dosage Trial by GlobeNewsWire
• BioAdaptives Welcomes UFC Senior Executive Reed Harris to Its Board of Advisors by GlobeNewsWire
• BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors by GlobeNewsWire
• BioAdaptives Announces FINRA Approval of a Dividend for Common Stock Shareholders by GlobeNewsWire
• BioAdaptives, Inc. Launches Xcellara™ Stem Cell Activator – Harnessing Nature for Optimal Health by GlobeNewsWire

BIOAFFINITY TECHNOLOGIES INC.

BIOAGE LABS INC.

• Fast Forward No. 779 by William Blair
• Fast Forward No. 778 by William Blair
• ACR 2025 Abstract Highlights and Conference Itinerary by William Blair
• William Blair’s Innovator Series – The Next Frontier in Cardiovascular Risk: Lp(a); November 5, 9:30 a.m.–2:30 p.m. ET by William Blair
• Fast Forward No. 777 by William Blair
• Today, at 12:00 p.m. ET: Third-Quarter Earnings Preview and Upcoming Catalysts Call With Biotech Team by William Blair
• Equity Research Rewind: Third Quarter 2025 by William Blair
• Fast Forward No. 776 by William Blair
• Third-Quarter Earnings Preview and Upcoming Catalysts Call With Biotech Team: Friday, October 10 at 12:00 p.m. ET by William Blair
• MFN Overhang Now Removed? Expanding Cash Pay Direct-to-Consumer Programs Might Give the Win-Win Scenario by William Blair

Bioalpha Holdings

• Bioalpha Holdings Berhad: 1 director by SmartInsider
• Insider sold/subscribed to: Two Directors sold/subscribed to 6,769,867 shares at between 0.200MYR and 0.215MYR. by SmartInsider
• Ford Equity International Rating and Forecast Report by Ford Equity Research